Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7972854 Methods and compositions for targeted cleavage and recombination

Patent 7972854 was granted and assigned to Sangamo Biosciences Inc. on July, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12129223 Lipids for use in lipid nanoparticle formulations
0
Edits on 23 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12122846 Chimeric antigen receptor for tumor targeting
0
Edits on 8 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11976019 Cationic lipids for use in lipid nanoparticles
0
Edits on 12 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11920169 Compositions for linking DNA-binding domains and cleavage domains
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11920148 Compositions and methods for gene editing
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834686 Engineered target specific base editors
0
Edits on 28 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 28 Nov, 2023
Edits made to:
Article (+266 characters)
Article

Patent abstract

Disclosed herein are methods and compositions for targeted cleavage of a genomic sequence, targeted alteration of a genomic sequence, and targeted recombination between a genomic region and an exogenous polynucleotide homologous to the genomic region.

Edits on 19 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 19 Sep, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jeffrey C. Miller0
Lei Zhang0
Edits on 15 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 15 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07972854 Methods and compositions for targeted cleavage and recombination US Patent 7972854 Methods and compositions for targeted cleavage and recombination

Infobox
Patent Number
079728540
Patent Number
79728540
Edits on 3 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
079728540
Date of Patent
July 5, 2011
0
Patent Application Number
105877230
Date Filed
February 3, 2005
0
Patent Primary Examiner
‌
Jennifer Dunston
0
Edits on 8 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 8 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07972854 Methods and compositions for targeted cleavage and recombination

Infobox
Is a
Patent
Patent
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07972854
Date of patent
July 5, 2011
Patent application number
10587723
Date Filed
February 3, 2005
Patent primary examiner
‌
Jennifer Dunston

Find more entities like US Patent 7972854 Methods and compositions for targeted cleavage and recombination

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.